Home › Calculator › SBMFF Dividend Calculator 2026
SBMFF Dividend DRIP Calculator 2026
2.01% YieldHealthcareSino Biopharmaceutical Limited · OTC
Price: $0.64 · Annual div: $0.01/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SBMFF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SBMFF snowball 📈
$10,000 in SBMFF → $274.6K in 10 years · $317.42/month
About Sino Biopharmaceutical Limited (SBMFF) — Dividend Analysis 2026
Sino Biopharmaceutical Limited operates as a leading investment holding entity and a research and development-focused pharmaceutical conglomerate, primarily active within the People's Republic of China. Its business activities are organized into three primary divisions: Modernised Chinese Medicines and Chemical Medicines, Investment initiatives, and other miscellaneous operations. The company offers a comprehensive range of pharmaceutical products spanning various therapeutic areas. This portfolio includes oncology medications like Qingkeshu, Anxian, Yinishu, Genike, Anyue capsules, and Leweixin injections; cardio-cerebral vascular drugs such as Kaina and Anrixin tablets; and treatments for hepatitis, including Tianqingganmei injections and Tianqingganping enteric capsules. It also produces orthopedic medicines like Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medications; parenteral nutritious solutions such as Xinhaineng and Fenghaina injections; and other pharmaceuticals, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. Furthermore, its advanced drug offerings feature specific products like Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. Beyond its core pharmaceutical manufacturing, Sino Biopharmaceutical engages in a diverse set of related healthcare and commercial ventures. These encompass managing properties; the retail and distribution of pharmaceutical goods; providing optometry services and selling ophthalmic products; operating hospitals; and offering medical management, health information consultancy, and bio-tech transfer and advisory services. The company also manufactures and markets health food, performs orthopedic outpatient and surgical procedures, develops medical and health technologies, trades optical eyewear, and is involved in the research, development, and sale of medical devices and active pharmaceutical ingredients. The company was established in 2000 and has its corporate headquarters situated in Wan Chai, Hong Kong.
Compare SBMFF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SBMFF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SBMFF position with:
🌍 SBMFF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SBMFF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.01% | -0.79% | $201 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.71% | -1.09% | $171 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.61% | -1.19% | $161 / yr |
| 🇬🇧 UK ISA | 0% | 2.01% | -0.79% | $201 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.83% | -0.97% | $183 / yr |
| 🇨🇦 TFSA | 0% | 2.01% | -0.79% | $201 / yr |
| 🇨🇦 CA Taxable | 25% | 1.51% | -1.29% | $151 / yr |
| 🇦🇺 Super (pension) | 15% | 1.71% | -1.09% | $171 / yr |
| 🇦🇺 AU Taxable | 30% | 1.41% | -1.39% | $141 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.48% | -1.32% | $148 / yr |
| 🇫🇷 FR Taxable | 30% | 1.41% | -1.39% | $141 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SBMFF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.01/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SBMFF Dividend Payment Schedule
SBMFF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SBMFF vs Healthcare Benchmarks
How SBMFF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SBMFF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SBMFF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SBMFF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Sino Biopharmaceutical Limited (SBMFF) is currently trading at $0.64, 44% below its 52-week high. The current dividend yield is 2.01% based on an annual payout of $0.01 per share.
SBMFF (Sino Biopharmaceutical Limited) — 2.01% Dividend Yield Analysis
Sino Biopharmaceutical Limited (SBMFF) is a healthcare stock currently trading at $0.64 with a dividend yield of 2.01%. The company pays an annual dividend of $0.01 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, SBMFF has grown its dividend at a compound annual rate of 32.2%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.